Gastric cancer is the subject of clinical and basic studies due to its high incidence and mortality rates worldwide. Due to the diagnosis occurring in advanced stages and the classic treatment methodologies such as gastrectomy and chemotherapy, they are extremely aggressive and limit the quality of life of these patients. CRISPR/Cas9 is a tool that allows gene editing and has been used to explore the functions of genes related to gastric cancer, in addition to being used in the treatment of this neoplasm, greatly increasing our understanding of cancer genomics. In this mini-review, we seek the current status of the CRISPR/Cas9 gene-editing technology in gastric cancer research and clinical research.
机构:
Ankara Univ, Dept Med Biochem, Fac Med, Ankara, Turkiye
Ankara Univ, Grad Sch Hlth Sci, Ankara, TurkiyeAnkara Univ, Dept Med Biochem, Fac Med, Ankara, Turkiye
Nojadeh, Jafar Nouri
Eryilmaz, Nur Seren Bildiren
论文数: 0引用数: 0
h-index: 0
机构:
Ankara Univ, Dept Internal Med, Fac Med, Ankara, TurkiyeAnkara Univ, Dept Med Biochem, Fac Med, Ankara, Turkiye
Eryilmaz, Nur Seren Bildiren
Erguder, Berrin Imge
论文数: 0引用数: 0
h-index: 0
机构:
Ankara Univ, Dept Med Biochem, Fac Med, Ankara, Turkiye
Ankara Univ, Grad Sch Hlth Sci, Ankara, Turkiye
Ankara Univ, Ibn i Sina Hosp, Dept Med Biochem, Fac Med, Ankara, TurkiyeAnkara Univ, Dept Med Biochem, Fac Med, Ankara, Turkiye